Loading data for SGP — first visit, this takes a few seconds.
SpyGlass Pharma, Inc. (SGP)
NasdaqGS: SGP
· 即時價格 · USD
26.50
+0.40 (1.53%)
收盤價： Sep 10, 2026, 8:00 PM
27.31
+0.00%
盤後: 7:30 PM
股價、關鍵數字和最新消息，都在這一頁。
SpyGlass Pharma, Inc.（SGP）股價、分析與資料
無可用資料
| 買價 | 19.14 |
| 市值 | 913M |
| 營收 (ttm) | n/a |
| 淨利（ttm） | -56.1M |
| 0.00 | |
| -1.67 | |
| n/a | |
| -10.05 | |
| P/B (ttm) | 3.93 |
| P/S (ttm) | 0.00 |
| 財報日期 | Nov 5, 2026 |
| 賣價 | 33.52 |
| 成交量 | 27,486 |
| 20 日平均成交量 | 115,247 |
| 開盤價 | 25.25 |
| 前收盤價 | 26.10 |
| 當日區間 | 25.25 - 26.84 |
| 52 週範圍 | 17.06 - 32.44 |
| 分析師 | n/a |
| 目標價 | n/a |
| 股利 | n/a |
| 除息日 | n/a |
關於 SGP
SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions. The company develops the Bimatoprost Drug Pad-IOL System (BIM-IOL System), including novel and proprietary drug pads attached to an intraocular lens (IOL), which is designed to be implanted during routine cataract surgery to reduce elevated intraocular pressure (IOP) in patients. It also develops...
完整的公司簡介財報驚奇
SpyGlass Pharma 已於 Aug 6, 2026 公布季度財報：
- 營收為 $0 低於預期 $0, 年增 NaN% 成長.
- 每股盈餘為 -0.59 低於預期 -0.04, 年增 -Infinity% 下滑.
